Deception of subjects in neuroscience: An ethical analysis

Journal of Neuroscience

Volumn 28, Issue 19, 2008, Pages 4841-4843

  Miller, Franklin G ^a   Kaptchuk, Ted J ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL LITERATURE; MEDICAL RESEARCH; NEUROSCIENCE; NOTE; PRIORITY JOURNAL; PUBLICATION; RECUMBENCY; ARTICLE; ETHICS; HUMAN; METHODOLOGY; PERSONAL AUTONOMY; RESEARCH ETHICS;

DECEPTION; ETHICS, RESEARCH; HUMANS; NEUROSCIENCES; PERIODICALS AS TOPIC; PERSONAL AUTONOMY; RESEARCH DESIGN;

EID: 44949088548     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1493-08.2008     Document Type: Note

References (15)

1. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK (2005) Neurobiological mechanisms of the placebo effect. J Neurosci 25:10390 -10402.
2. Charron J, Rainville P, Marchand S (2006) Direct comparison of placebo effects on clinical and experimental pain. Clin J Pain 22:204-211.
3. Department of Health and Human Services (1991) Protection of human subjects. Code of Federal Regulations, 45CFR46.116.(d).
4. Guess HA, Kleinman A, Kusek JW, Engel LW (2002) The science of the placebo. London: BMJ Books.
5. Kaptchuk TJ (1998) Powerful placebo: the dark side of the randomised controlled trial. Lancet 351:1722-1725.
6. Kong J, Gollub RL, Rosman IS, Webb JM, Vangel MG, Kirsch I, Kaptchuk TJ (2006) Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci 26:381-388.
7. Korn JH (1997) Illusions of reality: a history of deception in social psychology. Albany: State University of New York.
8. Miller FG, Rosenstein DL (2002) Reporting of ethical issues in publications of medical research. Lancet 360:1326-1328.
9. Miller FG, Wendler D, Swartzman L (2005) Deception in research on the placebo effect. PLoS Med 2:e262.
10. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1979) The Belmont report. Washington, DC: U.S. Government Printing Office.
11. Plassmann H, O'Doherty J, Shiv G, Rangel A (2008) Marketing actions can modulate neural representations of experienced pleasantness. Proc Natl Acad Sci USA 105:1050-1054.
12. Scott DJ, Stohler CS, Egnatuk CM, Wange H, Koeppe RA, Zubieta JK (2008) Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 65:220-231.
13. Sieber JE (1983) Deception in social research III: the nature and limits of debriefing. IRB 5:1-6.
14. Vase I, Riley J, Price D (2002) A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99:443-452.
15. Wendler D, Miller FG (2004) Deception in pursuit of science. Arch Intern Med 164:597-600.